Former FDA commissioner Robert Califf says form FDA-483 is a useful regulatory tool for identifying issues that companies should correct, but it should not be used as a proxy for a company’s overall quality.
FDA warns Henan, China-based Henan Lvyuan Pharmaceutical Company about significant deviations from current good manufacturing practices for active pharmaceutical ingredients.
Former FDA commissioner Robert Califf says form FDA-483 is a useful regulatory tool for identifying issues that companies should correct, but it should not be used as a proxy for a company’s overall quality.
FDA warns Henan, China-based Henan Lvyuan Pharmaceutical Company about significant deviations from current good manufacturing practices for active pharmaceutical ingredients.
A Washington Legal Foundation background document suggests that Congress change direct-to-consumer disclaimer rules to recognize the availability of smartphone technology and QR codes.
Researchers at the University of Cincinnati begin a new study to investigate whether widely used diabetes and weight-loss drugs could help prevent or delay Alzheimer’s disease.
